Literature DB >> 16159780

Analysis of putative Chlamydia trachomatis chaperones Scc2 and Scc3 and their use in the identification of type III secretion substrates.

Kenneth A Fields1, Elizabeth R Fischer, David J Mead, Ted Hackstadt.   

Abstract

The obligate intracellular pathogen Chlamydia trachomatis expresses a type III secretion system (T3SS) which has the potential to contribute significantly to pathogenesis. Based on a demonstrated role of type III secretion (T3S)-specific chaperones in the secretion of antihost proteins by gram-negative pathogens, we initiated a study of selected putative Chlamydia T3S chaperones in an effort to gain mechanistic insight into the Chlamydia T3SS and to potentially identify Chlamydia-specific secreted products. C. trachomatis Scc2 and Scc3 are homologous to SycD of Yersinia spp. Functional studies of the heterologous Yersinia T3SS indicated that although neither Scc2 nor Scc3 was able to fully complement a sycD null mutant, both have SycD-like characteristics. Both were able to associate with the translocator protein YopD, and Scc3 expression restored limited secretion of YopD in in vitro studies of T3S. CopB (CT578) and CopB2 (CT861) are encoded adjacent to scc2 and scc3, respectively, and have structural similarities with the YopB family of T3S translocators. Either Scc2 or Scc3 coprecipitates with CopB from C. trachomatis extracts. Expression of CopB or CopB2 in Yersinia resulted in their type III-dependent secretion, and localization studies with C. trachomatis-infected cells indicated that both were secreted by Chlamydia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16159780      PMCID: PMC1236624          DOI: 10.1128/JB.187.18.6466-6478.2005

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  50 in total

1.  Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes.

Authors:  W Baehr; Y X Zhang; T Joseph; H Su; F E Nano; K D Everett; H D Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Restriction of DNA in Yersinia enterocolitica detected by recipient ability for a derepressed R factor from Escherichia coli.

Authors:  G Cornelis; C Colson
Journal:  J Gen Microbiol       Date:  1975-04

4.  Molecular cloning of the temperature-inducible outer membrane protein 1 of Yersinia pseudotuberculosis.

Authors:  I Bölin; H Wolf-Watz
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

5.  The type III secretion chaperone LcrH co-operates with YopD to establish a negative, regulatory loop for control of Yop synthesis in Yersinia pseudotuberculosis.

Authors:  M S Francis; S A Lloyd; H Wolf-Watz
Journal:  Mol Microbiol       Date:  2001-11       Impact factor: 3.501

6.  Identification and cloning of a hemin storage locus involved in the pigmentation phenotype of Yersinia pestis.

Authors:  R D Perry; M L Pendrak; P Schuetze
Journal:  J Bacteriol       Date:  1990-10       Impact factor: 3.490

7.  Analysis of the V antigen lcrGVH-yopBD operon of Yersinia pseudotuberculosis: evidence for a regulatory role of LcrH and LcrV.

Authors:  T Bergman; S Håkansson; A Forsberg; L Norlander; A Macellaro; A Bäckman; I Bölin; H Wolf-Watz
Journal:  J Bacteriol       Date:  1991-03       Impact factor: 3.490

8.  Chlamydia trachomatis type III secretion: evidence for a functional apparatus during early-cycle development.

Authors:  K A Fields; D J Mead; C A Dooley; T Hackstadt
Journal:  Mol Microbiol       Date:  2003-05       Impact factor: 3.501

9.  Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis.

Authors:  H D Caldwell; J Kromhout; J Schachter
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

10.  Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis.

Authors:  Robert J Belland; Guangming Zhong; Deborah D Crane; Daniel Hogan; Daniel Sturdevant; Jyotika Sharma; Wandy L Beatty; Harlan D Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-18       Impact factor: 12.779

View more
  43 in total

1.  Domain analyses reveal that Chlamydia trachomatis CT694 protein belongs to the membrane-localized family of type III effector proteins.

Authors:  Holly D Bullock; Suzanne Hower; Kenneth A Fields
Journal:  J Biol Chem       Date:  2012-06-18       Impact factor: 5.157

2.  Structure and protein-protein interaction studies on Chlamydia trachomatis protein CT670 (YscO Homolog).

Authors:  Emily Lorenzini; Alexander Singer; Bhag Singh; Robert Lam; Tatiana Skarina; Nickolay Y Chirgadze; Alexei Savchenko; Radhey S Gupta
Journal:  J Bacteriol       Date:  2010-03-26       Impact factor: 3.490

Review 3.  Genetic variation in Chlamydia trachomatis and their hosts: impact on disease severity and tissue tropism.

Authors:  Hossam Abdelsamed; Jan Peters; Gerald I Byrne
Journal:  Future Microbiol       Date:  2013-09       Impact factor: 3.165

4.  Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle.

Authors:  K Wolf; H J Betts; B Chellas-Géry; S Hower; C N Linton; K A Fields
Journal:  Mol Microbiol       Date:  2006-09       Impact factor: 3.501

5.  Chlamydial type III secretion system is encoded on ten operons preceded by sigma 70-like promoter elements.

Authors:  P Scott Hefty; Richard S Stephens
Journal:  J Bacteriol       Date:  2006-10-20       Impact factor: 3.490

6.  A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice.

Authors:  Jie Wang; Lili Chen; Fan Chen; Xiaoyun Zhang; Yingqian Zhang; Joel Baseman; Sondra Perdue; I-Tien Yeh; Rochelle Shain; Martin Holland; Robin Bailey; David Mabey; Ping Yu; Guangming Zhong
Journal:  Vaccine       Date:  2009-03-10       Impact factor: 3.641

Review 7.  New frontiers in type III secretion biology: the Chlamydia perspective.

Authors:  K E Mueller; G V Plano; K A Fields
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

Review 8.  Chlamydia trachomatis strains and virulence: rethinking links to infection prevalence and disease severity.

Authors:  Gerald I Byrne
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

9.  Reversal of the antichlamydial activity of putative type III secretion inhibitors by iron.

Authors:  Anatoly Slepenkin; Per-Anders Enquist; Ulrik Hägglund; Luis M de la Maza; Mikael Elofsson; Ellena M Peterson
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

10.  Induction of type III secretion by cell-free Chlamydia trachomatis elementary bodies.

Authors:  Wendy P Jamison; Ted Hackstadt
Journal:  Microb Pathog       Date:  2008-10-17       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.